| scholarly article | Q13442814 |
| P50 | author | Chung Mo Nam | Q59679916 |
| Chulwoo Ahn | Q73435787 | ||
| P2093 | author name string | Hyon K Choi | |
| Seung-Hoon Lee | |||
| Yong-Beom Park | |||
| Soo-Kon Lee | |||
| Hyun-Chul Lee | |||
| Byung-Hyun In | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study | Q33561343 | ||
| Analysis of serial measurements in medical research | Q35167613 | ||
| Death Rate and Causes of Death in Patients with Rheumatoid Arthritis | Q42139986 | ||
| Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
| Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis | Q43622165 | ||
| How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? | Q43626430 | ||
| Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis | Q43651890 | ||
| Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study | Q45221518 | ||
| On quantifying plaque size and intima-media thickness in carotid and femoral arteries. Comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia | Q47329367 | ||
| Reproducibility of extracranial carotid atherosclerotic lesions assessed by B-mode ultrasound: the Atherosclerosis Risk in Communities Study. | Q50991511 | ||
| Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. | Q51014269 | ||
| A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 | ||
| Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging | Q56554483 | ||
| P433 | issue | 7 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1714-1719 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound | |
| P478 | volume | 46 |
| Q35631101 | A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects. |
| Q35932689 | Accelerated atherosclerosis in inflammatory rheumatic diseases |
| Q36951047 | Accelerated atherosclerosis in rheumatoid arthritis |
| Q37690126 | Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis |
| Q35907814 | Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease |
| Q36984426 | Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis |
| Q89411784 | Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid |
| Q35552716 | Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis |
| Q51610024 | Arterial stiffness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors. |
| Q35110147 | Asymptomatic atherosclerosis in egyptian rheumatoid arthritis patients and its relation to disease activity |
| Q36726386 | Atherosclerosis and inflammation: insights from rheumatoid arthritis |
| Q35553376 | Atherosclerotic cardiovascular disease in rheumatoid arthritis |
| Q36465464 | Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation |
| Q35808632 | Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis |
| Q35557796 | Cardiovascular co-morbidity in patients with rheumatic diseases. |
| Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
| Q37808570 | Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications |
| Q30240180 | Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis. |
| Q37796382 | Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis |
| Q28085227 | Causes of changes in carotid intima-media thickness: a literature review |
| Q36392394 | Cells of the synovium in rheumatoid arthritis. Dendritic cells. |
| Q35954510 | Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis |
| Q35856595 | Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. |
| Q37691111 | Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. |
| Q51801169 | Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. |
| Q35557952 | Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease |
| Q34389625 | Cutaneous markers of coronary artery disease |
| Q34975993 | Decoding the differential biomarkers of Rheumatoid arthritis and Osteoarthritis: A functional genomics paradigm to design disease specific therapeutics |
| Q33964367 | Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? |
| Q45184227 | Effect of glucocorticoids on the arteries in rheumatoid arthritis |
| Q44204800 | Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease |
| Q64984979 | Effects of Adalimumab, an Anti-tumour Necrosis Factor-Alpha (TNF-α) Antibody, on Obese Diabetic Rats. |
| Q37930979 | Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians |
| Q35636932 | Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome |
| Q34185602 | Gluten-free diet in nonceliac disease |
| Q36757006 | Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. |
| Q51835838 | Immune-Mediated Heart Disease. |
| Q34712199 | Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations |
| Q35854740 | Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis |
| Q35554431 | Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study |
| Q38206843 | Individualized cardiovascular risk assessment by cardiovascular magnetic resonance |
| Q44652560 | Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis |
| Q44958376 | Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis |
| Q37245192 | Infliximab improves vascular stiffness in patients with rheumatoid arthritis |
| Q35152141 | Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis |
| Q84135341 | Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population |
| Q53341641 | Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. |
| Q35555347 | Lower limb arterial incompressibility and obstruction in rheumatoid arthritis |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q38846584 | Menopause and Rheumatic Disease |
| Q36204149 | Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis |
| Q51824867 | Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behcet's disease. |
| Q24812557 | Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis |
| Q37947846 | Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease |
| Q73207949 | New evidence for vascular disease in patients with early rheumatoid arthritis |
| Q37328983 | Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study |
| Q38499216 | Periodontal pathogens are likely to be responsible for the development of ankylosing spondylitis |
| Q37296393 | Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance |
| Q90090165 | Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa |
| Q50776302 | Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients. |
| Q36574986 | Rheumatoid arthritis and the heart |
| Q41936429 | Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. |
| Q24812262 | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study |
| Q35160608 | Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients |
| Q37027316 | Statin treatment for rheumatoid arthritis: a promising novel indication |
| Q36968832 | Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus |
| Q43061735 | Subclinical atherosclerosis in scleroderma patients |
| Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
| Q38671481 | The dynamic evolution of rheumatology in Korea |
| Q37206876 | The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus |
| Q43488992 | The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. |
| Q37817050 | The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis |
| Q36577503 | Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis |
| Q53021496 | Tissue Doppler imaging in the evaluation of the left and right ventricular diastolic functions in rheumatoid arthritis. |
| Q37859678 | Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis |
| Q33646347 | Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study |
| Q35630128 | Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis |
| Q35954625 | What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. |
Search more.